The University of Chicago Header Logo

Peter Riedell

Concepts (141)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse
16
2023
135
3.930
Why?
Immunotherapy, Adoptive
13
2023
155
2.660
Why?
Hematopoietic Stem Cell Transplantation
11
2023
865
2.350
Why?
Lymphoma, Mantle-Cell
3
2023
33
1.910
Why?
Lymphoma, Non-Hodgkin
5
2023
259
1.450
Why?
Antigens, CD19
10
2023
39
1.430
Why?
Lymphoma, B-Cell
5
2022
102
1.350
Why?
Transplantation, Autologous
6
2021
324
1.120
Why?
Jehovah's Witnesses
1
2021
18
0.810
Why?
Blood Component Removal
1
2020
24
0.810
Why?
Proto-Oncogene Proteins c-myc
2
2018
115
0.810
Why?
Proto-Oncogene Proteins c-bcl-2
2
2018
187
0.780
Why?
Biological Products
4
2023
136
0.770
Why?
Transplantation Conditioning
3
2021
372
0.760
Why?
Lymphoma
2
2018
259
0.720
Why?
Receptors, Antigen, T-Cell
5
2023
363
0.620
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2023
2390
0.580
Why?
Antibodies, Monoclonal, Murine-Derived
3
2016
78
0.570
Why?
Lymphoma, Follicular
3
2022
69
0.560
Why?
Graft vs Host Disease
3
2023
359
0.520
Why?
Hepatitis B virus
1
2014
38
0.510
Why?
Hepatitis B
1
2014
69
0.490
Why?
Humans
42
2023
83873
0.470
Why?
B-Lymphocytes
1
2017
712
0.460
Why?
Gene Expression Profiling
1
2017
1355
0.430
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2023
135
0.420
Why?
Neoplasm Recurrence, Local
9
2023
1257
0.420
Why?
Antineoplastic Agents, Immunological
2
2023
185
0.380
Why?
Cell- and Tissue-Based Therapy
4
2023
49
0.370
Why?
Retrospective Studies
8
2023
8061
0.350
Why?
Antineoplastic Agents
3
2023
2324
0.350
Why?
T-Lymphocytes
4
2021
1176
0.300
Why?
Sarcopenia
2
2016
13
0.300
Why?
Aged
13
2023
18098
0.280
Why?
Tumor Lysis Syndrome
1
2023
9
0.240
Why?
Adult
11
2023
25203
0.240
Why?
Survival Analysis
3
2023
1531
0.230
Why?
Veterans
4
2016
64
0.230
Why?
Rituximab
4
2016
113
0.220
Why?
Middle Aged
11
2022
24691
0.220
Why?
Hodgkin Disease
1
2023
173
0.210
Why?
Geriatric Assessment
2
2020
161
0.210
Why?
5-Methylcytosine
1
2022
106
0.210
Why?
Thrombocytopenia
1
2022
177
0.210
Why?
United States
7
2023
6425
0.200
Why?
Prognosis
2
2018
3618
0.190
Why?
Antibodies, Monoclonal, Humanized
2
2023
918
0.190
Why?
Cladribine
1
2019
35
0.190
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2020
41
0.190
Why?
Carcinoma
1
2023
427
0.180
Why?
Hematologic Neoplasms
1
2023
321
0.180
Why?
Male
13
2023
40239
0.180
Why?
Interdisciplinary Communication
1
2019
127
0.170
Why?
Patient Selection
2
2019
680
0.170
Why?
Female
12
2023
43741
0.160
Why?
Disease Management
1
2019
323
0.160
Why?
Patient Care Team
1
2019
274
0.160
Why?
Preoperative Care
1
2019
393
0.160
Why?
Central Nervous System Neoplasms
1
2018
80
0.160
Why?
Multiple Myeloma
1
2020
299
0.150
Why?
Translocation, Genetic
1
2017
265
0.150
Why?
Obesity, Abdominal
1
2016
7
0.150
Why?
Cyclophosphamide
4
2021
296
0.150
Why?
Remission Induction
3
2023
709
0.150
Why?
Body Composition
1
2016
64
0.140
Why?
Up-Regulation
1
2018
698
0.140
Why?
Recurrence
3
2023
1136
0.140
Why?
Maximum Tolerated Dose
1
2016
270
0.140
Why?
Stem Cell Transplantation
3
2021
181
0.140
Why?
Anthracyclines
1
2015
35
0.130
Why?
Pneumonia, Viral
1
2020
310
0.130
Why?
Doxorubicin
4
2016
284
0.130
Why?
Coronavirus Infections
1
2020
295
0.130
Why?
Survivors
1
2016
217
0.130
Why?
Febrile Neutropenia
1
2014
14
0.130
Why?
Pandemics
1
2020
693
0.120
Why?
Heart Failure
1
2023
1153
0.120
Why?
Venous Thromboembolism
1
2016
143
0.120
Why?
Leukemia, Myeloid, Acute
1
2019
737
0.120
Why?
Transplantation, Homologous
3
2020
985
0.120
Why?
Bridged Bicyclo Compounds, Heterocyclic
2
2023
73
0.120
Why?
Gene Expression Regulation, Neoplastic
1
2018
1181
0.120
Why?
Clinical Trials as Topic
1
2018
1155
0.120
Why?
Time Factors
1
2021
5176
0.110
Why?
Adolescent
2
2023
8806
0.110
Why?
Vincristine
3
2016
109
0.110
Why?
Prednisone
3
2016
254
0.100
Why?
Body Mass Index
1
2014
764
0.100
Why?
Antiviral Agents
1
2014
494
0.100
Why?
Neoplasms
1
2023
2794
0.080
Why?
Pilot Projects
2
2021
816
0.080
Why?
Antibodies, Monoclonal
1
2014
1357
0.080
Why?
Prospective Studies
3
2023
4090
0.080
Why?
Aged, 80 and over
3
2021
6453
0.060
Why?
Troponin
1
2023
18
0.060
Why?
Melphalan
1
2023
96
0.060
Why?
Outpatients
1
2023
87
0.060
Why?
C-Reactive Protein
1
2023
189
0.060
Why?
Interleukin-6
1
2023
240
0.050
Why?
Thiotepa
1
2021
32
0.050
Why?
Histiocytes
1
2021
22
0.050
Why?
B7-H1 Antigen
1
2023
242
0.050
Why?
Sulfonamides
1
2023
297
0.050
Why?
Incidence
2
2016
1565
0.050
Why?
Central Nervous System
1
2021
148
0.050
Why?
Treatment Outcome
3
2019
7776
0.050
Why?
Health Planning Guidelines
1
2019
24
0.050
Why?
Chimerism
1
2020
37
0.050
Why?
Filgrastim
1
2019
56
0.050
Why?
Communicable Disease Control
1
2020
50
0.050
Why?
Hydrazines
1
2019
29
0.050
Why?
Health Care Rationing
1
2020
79
0.050
Why?
Health Plan Implementation
1
2019
56
0.050
Why?
Standard of Care
1
2019
78
0.050
Why?
Triazoles
1
2019
96
0.040
Why?
Cytarabine
1
2019
216
0.040
Why?
Drug Resistance, Neoplasm
1
2021
580
0.040
Why?
Epigenesis, Genetic
1
2022
447
0.040
Why?
Palliative Care
1
2019
241
0.040
Why?
Clinical Decision-Making
1
2019
252
0.040
Why?
Tissue Donors
1
2020
442
0.040
Why?
Steroids
1
2018
170
0.040
Why?
Biomarkers
1
2023
1654
0.040
Why?
Abdominal Fat
1
2016
13
0.040
Why?
Subcutaneous Fat
1
2016
16
0.040
Why?
Neutropenia
1
2016
213
0.040
Why?
Cohort Studies
1
2021
2703
0.030
Why?
Antibiotics, Antineoplastic
1
2015
109
0.030
Why?
Proportional Hazards Models
1
2016
852
0.030
Why?
Muscle, Skeletal
1
2016
438
0.030
Why?
Mice, Inbred C57BL
1
2019
3025
0.030
Why?
Longitudinal Studies
1
2016
980
0.030
Why?
Practice Guidelines as Topic
1
2020
1033
0.030
Why?
Animals
2
2023
26005
0.030
Why?
Mutation
1
2022
3889
0.020
Why?
Hospitalization
1
2016
809
0.020
Why?
Mice
1
2023
10930
0.020
Why?
Young Adult
1
2019
5843
0.020
Why?
Tomography, X-Ray Computed
1
2016
2497
0.020
Why?
Magnetic Resonance Imaging
1
2018
3253
0.020
Why?
Risk Factors
1
2016
5301
0.020
Why?
Riedell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (141)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_